NCT01381328
GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance No drug interventions Not Available Not Available unknown_status NCT03044379
Dapivirine Gel Rectal Safety and PK Study other 1 withdrawn NCT05458102
Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels treatment 1 terminated NCT01032408
Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection No drug interventions prevention 3 completed NCT01692470
A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection Not Available Not Available withdrawn NCT00257621
GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults treatment 2 completed NCT00242879
A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults treatment 2 terminated NCT00044577
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects treatment 3 completed NCT00549198
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects treatment 4 completed NCT00089583
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection treatment 2 completed NCT00102778
GW873140 In Combination With Kaletra In HIV Infected Subjects treatment 2 terminated NCT01227824
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily treatment 3 completed NCT00046176
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients treatment 3 completed NCT00082394
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV treatment 4 completed NCT00104429
GW873140 In Combination With Combivir In HIV Infected Subjects treatment 2 terminated NCT03327740
PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) Not Available Not Available completed NCT01205243
ZIAGEN® Post-marketing Surveillance Not Available Not Available completed NCT00481390
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients No drug interventions Not Available Not Available completed NCT00440947
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection treatment 3 completed NCT00197145
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects treatment 3 terminated NCT01263015
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) treatment 3 completed NCT01283100
A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects. Not Available 1 withdrawn NCT01597648
A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ Not Available 1 completed NCT00450580
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults treatment 3 completed NCT00242840
Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) No drug interventions Not Available 3 completed NCT00094523
Fosamprenavir Versus Other Protease Inhibitors treatment 3 completed NCT01078233
Observational Data Analysis in EuroSIDA (MK-0518-058) No drug interventions Not Available Not Available completed NCT01138605
TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV treatment 2 completed NCT01013415
CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients No drug interventions treatment 1 completed NCT01159275
Lopinavir (LPV) Dose Reduction No drug interventions other 1 / 2 completed NCT01281813
TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV treatment 3 completed NCT01151319
Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults No drug interventions prevention 1 completed NCT00830804
Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults treatment 2 completed NCT00557245
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples prevention 3 completed NCT01139905
Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children No drug interventions Not Available 2 completed NCT02593409
HIV PrEP Priming of Immune Effectors prevention 4 unknown_status NCT00984152
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women treatment 3 withdrawn NCT00799058
A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States prevention 1 / 2 completed NCT01074931
Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China Not Available Not Available completed NCT01033760
Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM) treatment 3 completed NCT01078246
Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268) No drug interventions Not Available Not Available completed NCT05052996
Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV treatment 2 active_not_recruiting NCT05582694
A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection treatment 2 recruiting NCT05705349
DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053) No drug interventions treatment 3 recruiting NCT06602622
Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI treatment 4 recruiting NCT01874743
Rosuvastatin to Decrease Residual Immune Activation in HIV Infection Not Available 2 unknown_status NCT01309243
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults treatment 3 completed NCT04568603
Islatravir and Methadone Pharmacokinetics (MK-8591-029) other 1 completed NCT01266902
A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1 treatment 3 completed NCT02247687
Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR) treatment 3 terminated NCT01637233
MARCH Central Nervous System Substudy Not Available Not Available completed NCT02590354
Analytical Treatment Interruption in HIV Positive Patients No drug interventions other Not Available completed NCT01019551
Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients No drug interventions treatment 2 completed NCT04564547
Dose Ranging, Switch Study of Islatravir (ISL) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013] treatment 2 active_not_recruiting NCT03272347
Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011) treatment 2 completed NCT01353898
Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003) No drug interventions treatment 1 terminated NCT03803605
Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons prevention 1 completed NCT02390297
Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients No drug interventions Not Available Not Available active_not_recruiting NCT00709397
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy No drug interventions Not Available Not Available terminated NCT03001128
Biomarkers to Predict Time to Plasma HIV RNA Rebound No drug interventions Not Available Not Available completed NCT02157311
4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients treatment 3 completed NCT03149211
To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults treatment 3 withdrawn NCT05631093
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051) No drug interventions treatment 3 active_not_recruiting NCT01928407
Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts treatment 4 completed NCT02603107
Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults treatment 3 completed NCT01511809
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression treatment 3 completed NCT01121809
Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily treatment 4 completed NCT01712256
Re-boosting of HIV-1 Infected Subjects With Vacc-4x No drug interventions treatment 2 completed NCT02155985
Modulation of Immune Activation by Aspirin treatment 2 completed NCT01352715
Study of Options for Second-Line Effective Combination Therapy (SELECT) treatment 3 completed NCT02026752
Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay No drug interventions Not Available Not Available completed NCT02345252
Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF) treatment 3 completed NCT04776252
Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033) No drug interventions treatment 3 active_not_recruiting NCT01296152
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women treatment 2 completed NCT06185452
Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine treatment 4 active_not_recruiting NCT02089659
A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Doravirine (MK-1439) (MK-1439-019) treatment 1 completed NCT04385875
Study to Assess the Safety and Durability of Viral Control Beyond 24 Weeks of Analytical Treatment Interruption After the Administration of Candidate HIV-1 Vaccines DNA.HTI, MVA.HTI and ChAdOx1.HTI or Placebo in Early Treated HIV-1 Positive Individuals (ATI Extension of AELIX-002 Study) No drug interventions other 1 completed NCT04138199
A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation No drug interventions Not Available Not Available terminated NCT01529749
Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated treatment 4 completed NCT01235013
Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3 treatment 4 unknown_status NCT01000818
A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) treatment 1 completed NCT01446718
A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years Not Available Not Available completed NCT01439841
The Effect of Probiotics in HIV-1 Infection No drug interventions treatment Not Available completed NCT02128217
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection treatment 1 completed NCT01352117
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma treatment 3 completed NCT02706717
Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers No drug interventions treatment 2 completed NCT03683524
EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS treatment 4 completed NCT02652624
Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women treatment 3 completed NCT04233216
Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019) treatment 3 completed NCT01213316
A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen) Not Available Not Available completed NCT01543958
Sevelamer for Reducing Endotoxemia and Immune Activation treatment 2 completed NCT02859558
Early ART to Limit Infection and Establishment of Reservoir treatment 2 active_not_recruiting NCT01969058
Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery treatment 2 completed NCT03405935
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years treatment 3 completed NCT03844386
Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults No drug interventions treatment 1 completed NCT03859739
Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002) No drug interventions treatment 1 completed NCT01484522
Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth Not Available Not Available completed NCT00993148
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 treatment 2 completed NCT00823966
Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients Not Available Not Available completed NCT03739866
Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults treatment 1 completed NCT02275065
Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants treatment 1 completed NCT05056974
A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs treatment 2 completed NCT02116374
Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients No drug interventions Not Available Not Available completed NCT02592174
Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study No drug interventions diagnostic Not Available completed NCT02603120
Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed treatment 3 completed NCT02881320
Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1 treatment 2 / 3 recruiting NCT00552682
Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+ treatment 3 completed NCT02441231
Probiotic Visbiome for Inflammation and Translocation in HIV II treatment 2 unknown_status NCT01903031
Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART treatment 2 completed NCT04406727
UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection treatment 3 not_yet_recruiting NCT01928927
Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) treatment 2 completed NCT01130376
Novel Interventions in HIV-1 Infection treatment 1 terminated NCT01894776
A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc other 1 completed NCT02264860
Researching Alveolar Macrophage Improvements With Supplements in HIV No drug interventions other Not Available completed NCT02397694
Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults treatment 2 completed NCT04041362
the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients treatment 2 withdrawn NCT02616029
Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I treatment 3 completed NCT01335529
Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin treatment 2 completed NCT04061889
Clinical Epidemiology Cohort Study for Patient Living With HIV No drug interventions Not Available Not Available unknown_status NCT02440789
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) treatment 1 / 2 completed NCT01082692
Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants No drug interventions treatment 1 completed NCT01453192
Renal Transplantation and Raltegravir in HIV-Infected Patients treatment 3 completed NCT01019044
Exploration of HIV Reservoirs No drug interventions Not Available Not Available completed NCT04811040
Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection treatment 1 completed NCT01252940
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF treatment 3 completed NCT00743340
Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine other 2 completed NCT01772940
Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting treatment 4 completed NCT01641367
A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure treatment 4 completed NCT02042001
Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects treatment 4 completed NCT02707601
Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment treatment 3 completed NCT01017172
Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients No drug interventions diagnostic 4 unknown_status NCT03835546
Study to Assess the ART Impact on the Brain Outcomes. The ARBRE Study No drug interventions Not Available Not Available completed NCT01153646
Gene Transfer for HIV Using Autologous T Cells No drug interventions Not Available 0 terminated NCT04133012
Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone No drug interventions basic_science Not Available completed NCT01400412
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen treatment 2 completed NCT01989910
Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients treatment 4 completed NCT00833781
A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects No drug interventions treatment 1 / 2 completed NCT00915655
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents treatment 2 completed NCT05630755
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052) treatment 3 active_not_recruiting NCT01152255
MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2) treatment 1 terminated NCT03070223
PREPARE (A5361s) Substudy of REPRIEVE (A5332) Not Available Not Available completed NCT03188523
Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002) No drug interventions treatment 1 completed NCT02770508
Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects treatment 4 completed NCT02887508
HIV Internet Sex Study: Internet-based STI/HIV Prevention for HIV+ Internet Users No drug interventions treatment Not Available completed NCT01427738
Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis treatment 3 completed NCT04003103
Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016) prevention 2 completed NCT01127464
DCVax Plus Poly ICLC in Healthy Volunteers basic_science 1 completed NCT02400021
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals treatment 2 unknown_status NCT02581202
The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation Not Available Not Available completed NCT02582684
Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients treatment 2 completed NCT04233879
Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020) treatment 3 active_not_recruiting NCT02212379
Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL treatment 2 completed NCT02370979
Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients treatment 4 unknown_status NCT03593187
A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma No drug interventions treatment 1 / 2 completed NCT00323687
SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada treatment 4 completed NCT02605954
Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults treatment 3 completed NCT01403051
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART treatment 2 completed NCT01315353
HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women No drug interventions treatment Not Available completed NCT03060447
Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers treatment 1 completed NCT03164447
UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients treatment 2 unknown_status NCT02446847
3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption No drug interventions treatment 2 completed NCT02246998
Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults treatment 4 completed NCT01777997
FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir treatment 4 completed NCT02557997
Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation No drug interventions Not Available Not Available unknown_status NCT01319383
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART treatment 1 / 2 completed NCT02616783
Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years treatment 3 completed NCT01338883
Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus treatment 2 completed NCT02473328
Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients treatment 2 completed NCT04802811
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects No drug interventions other 1 completed NCT02513771
Sitagliptin for Reducing Inflammation and Immune Activation treatment 2 completed NCT01627678
Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART treatment 1 / 2 completed NCT02566707
Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance Regimen treatment 2 terminated NCT01378156
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART No drug interventions treatment 1 completed NCT02607956
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults treatment 3 completed NCT01466985
A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005) treatment 1 completed NCT01492985
Lipopeptide Immunisation With GTU-multiHIV Trial No drug interventions treatment 2 completed NCT03588715
Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2) treatment 1 unknown_status NCT00892437
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults treatment 2 completed NCT02906137
Gut-Associated Lymphocyte Trafficking No drug interventions basic_science Not Available completed NCT03631732
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants treatment 3 completed NCT02542852
A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia treatment 2 completed NCT00534352
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment). treatment 2 completed NCT02707900
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection treatment 1 terminated NCT02174159
Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003) treatment 1 completed NCT01286259
Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals other Not Available completed NCT01097070
A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days treatment 2 completed NCT03351699
Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002) No drug interventions treatment 1 completed NCT02578706
Targeting Platelets in Chronic HIV Infection treatment 2 completed NCT03552536
MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002) No drug interventions treatment 1 completed NCT02412436
PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB treatment 2 completed NCT01436136
Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months No drug interventions prevention Not Available completed NCT01515813
Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation treatment 2 withdrawn NCT01480713
Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors treatment 3 completed NCT01435018
Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS treatment 3 completed NCT01549119
Phase I/IIa Dose-escalation Clinical Study of VAC-3S No drug interventions treatment 1 / 2 completed NCT02600819
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis treatment 3 completed NCT01145417
Pregabalin Trial In HIV Neuropathic Pain treatment 3 terminated NCT00556634
Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage treatment 4 completed NCT04137016
Pilot Study to Assess the Impact of a Mobile Health Application (App) on Clinical Outcomes and Satisfaction of Older HIV-Infected Patients, as an Emerging Tool for Care, Education and Prevention. No drug interventions supportive_care Not Available completed NCT02057796
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 prevention 4 completed NCT02527096
A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol) treatment 2 completed NCT02397096
Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) treatment 3 completed NCT02588586
A Study of the Safety and Antiretroviral Activity of 3BNC117 No drug interventions treatment 2 completed NCT02629822
Safety and Efficacy of Doravirine, Tenofovir, Lamivudine (MK-1439A) in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030) treatment 2 completed NCT01966822
Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density treatment 3 completed NCT01351025
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells treatment 2 completed NCT00398125
Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults treatment 2 completed NCT01950325
VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected... No drug interventions treatment 1 completed NCT02987530
National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection treatment 3 completed NCT02607930
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults treatment 3 completed NCT02818348
Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients basic_science 1 completed NCT02732457
Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients No drug interventions Not Available Not Available terminated NCT02345226
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults treatment 3 completed NCT02273765
Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis treatment 3 completed NCT02099474
Evaluation of Raltegravir During the Third Trimester of Pregnancy No drug interventions treatment 2 completed NCT02211482
Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study treatment 4 completed NCT01083173
Surveillance of Kaletra in Korean Patients No drug interventions Not Available Not Available completed NCT03743376
The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients treatment 2 completed NCT00849160
Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection. treatment 3 completed NCT05295394
Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study treatment 4 withdrawn NCT01632891
Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected treatment 1 / 2 completed NCT03122262
ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy treatment 3 completed NCT02777229
Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings treatment 3 completed NCT03212989
Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART) treatment 1 completed NCT01935089
Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV treatment 2 completed NCT02441244
Probiotic Visbiome for Inflammation and Translocation in HIV Ι treatment 2 terminated NCT01286740
Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR treatment 2 completed NCT02067767
Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD) treatment 2 completed NCT02858401
Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults treatment 1 completed NCT02605304
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF treatment 2 terminated NCT04620304
Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients treatment 1 completed NCT01092104
A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients treatment 1 / 2 completed NCT04295772
Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028) treatment 2 completed NCT02369146
To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults treatment 2 completed NCT02469246
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC treatment 3 completed NCT01489046
Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive treatment 2 terminated NCT02486510
Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication treatment 0 terminated NCT01704781
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) supportive_care 1 / 2 completed NCT01701895
Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera No drug interventions Not Available Not Available completed NCT01466595
Rifaximin as a Modulator of Microbial Translocation and Immune Activation treatment 2 completed NCT02121795
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF treatment 3 completed NCT02611895
Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy No drug interventions diagnostic Not Available completed NCT01714414
A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen treatment 2 completed NCT00894114
A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019) No drug interventions prevention 1 completed NCT01348308
Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients treatment 3 completed NCT01426438
Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate treatment 2 completed NCT06005610
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy treatment 2 recruiting NCT04820933
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV treatment 0 recruiting NCT03622177
Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection No drug interventions Not Available Not Available unknown_status NCT05071378
Leveraging Family-Based Assets for Black MSM In House Ball Communities No drug interventions prevention Not Available unknown_status NCT03986099
Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART No drug interventions diagnostic Not Available completed NCT02092116
Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir treatment 1 / 2 completed NCT05110963
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments No drug interventions treatment Not Available recruiting NCT03584048
Charlotte Retention in Care Study No drug interventions Not Available Not Available completed NCT00659789
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV treatment 2 completed NCT06214910
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa No drug interventions health_services_research Not Available recruiting NCT04568395
Acute Effects of TCIG vs ECIG in PLWH No drug interventions basic_science Not Available completed NCT05947890
Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa No drug interventions prevention 2 recruiting NCT04725877
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers No drug interventions prevention 1 completed NCT04618198
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa No drug interventions treatment 3 recruiting NCT06282783
Studying Topiramate for Re-Activating the HIV-1 Reservoir treatment 1 / 2 not_yet_recruiting NCT05601128
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA No drug interventions treatment 3 active_not_recruiting NCT05383456
The Visceral Adiposity Measurement and Observation Study No drug interventions Not Available Not Available completed NCT04585737
Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF treatment 4 completed NCT04887675
Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI No drug interventions prevention Not Available unknown_status NCT05421806
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/ No drug interventions Not Available Not Available completed NCT05187741
Effect of a Mobile Health Intervention on Treatment Adherence No drug interventions supportive_care Not Available completed NCT05187429
Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy treatment 1 / 2 recruiting NCT05854381
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV No drug interventions prevention 1 recruiting NCT04675255
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism No drug interventions diagnostic Not Available completed NCT05590455
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis treatment 2 recruiting NCT04971343
Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol No drug interventions Not Available Not Available completed NCT00937729
Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules No drug interventions Not Available Not Available terminated NCT05031819
Managing Hypertension Among People Living with HIV No drug interventions health_services_research Not Available active_not_recruiting NCT06253533
ICVAX as a HIV Therapeutic DNA Vaccine No drug interventions treatment 1 active_not_recruiting NCT06368453
A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test No drug interventions screening Not Available recruiting NCT05219916
Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses No drug interventions basic_science Not Available terminated NCT04132674
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed other 4 unknown_status NCT03101644
Optimization of Darunavir Therapy and Dosage Recommendations other 4 completed NCT03262441
MMF for HIV Reservoir Reduction treatment 2 completed NCT01304186
An Automated, Tailored Information Application for Medication Health Literacy No drug interventions treatment Not Available completed NCT01541631
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes prevention Not Available unknown_status NCT05261191
A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy No drug interventions treatment 1 completed NCT01381029
Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals No drug interventions Not Available Not Available completed NCT00642707
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection treatment 2 completed NCT01908049
Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection. No drug interventions treatment 2 unknown_status NCT05471076
Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV No drug interventions prevention 1 active_not_recruiting NCT05502341
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen treatment 2 / 3 recruiting NCT05546242
Improving HIV-1 Control in Africa with Long Acting Antiretrovirals treatment 3 active_not_recruiting NCT05828095
A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV No drug interventions prevention 1 active_not_recruiting NCT05869643
A Clinical Trial of STP0404 in Adults With HIV-1 Infection treatment 2 recruiting NCT06104306
Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER) treatment 4 recruiting NCT06333808
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy treatment 3 recruiting NCT06337032
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments treatment 4 recruiting NCT06444620
B/F/TAF to DTG/3TC Switch Study treatment 3 recruiting NCT06613685
Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated treatment 2 / 3 not_yet_recruiting NCT06532656
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 treatment 2 / 3 recruiting NCT03399903
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection prevention 1 / 2 completed NCT03199690
A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers treatment 1 unknown_status NCT04985890
A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir treatment 2 not_yet_recruiting NCT03251690
Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression treatment Not Available completed NCT06127290
HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia No drug interventions Not Available Not Available recruiting NCT03087890
Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria prevention 4 completed NCT03148964
Primary Infection Cohort No drug interventions Not Available Not Available recruiting NCT03719664
Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects treatment 2 unknown_status NCT03940521
Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment No drug interventions Not Available Not Available recruiting NCT05516602
Improving HIV Prevention Among Adolescent Girls and Young Women (AGYW) in Uganda No drug interventions prevention Not Available recruiting NCT04266002
HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy No drug interventions treatment Not Available completed NCT06205602
Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa treatment 2 not_yet_recruiting NCT05351684
Effect of Dolutegravir Intensification on HIV-1 Reservoirs treatment 2 completed NCT04668443
D²EFT Graphical Informed Consent No drug interventions Not Available Not Available completed NCT05433987
Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy No drug interventions Not Available Not Available completed NCT06393387
Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United States No drug interventions Not Available Not Available recruiting NCT06544733
Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed treatment 2 / 3 recruiting NCT05148754
An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers treatment 1 completed NCT04888754
A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands No drug interventions Not Available Not Available active_not_recruiting NCT04892654
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch treatment 3 recruiting NCT05122754
Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection No drug interventions treatment 4 active_not_recruiting NCT04605354
Epidemiological and Clinical Description of Women Living With HIV in Selected Countries of Latin America No drug interventions Not Available Not Available unknown_status NCT04526977
Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis). No drug interventions Not Available Not Available recruiting NCT03340077
The Medicines Optimisation Review Toolkit Evaluation in HIV Outpatients No drug interventions supportive_care Not Available completed NCT05129345
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US No drug interventions Not Available Not Available recruiting NCT03311945
Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM treatment 3 unknown_status NCT05222945
A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide No drug interventions basic_science Not Available not_yet_recruiting NCT05275998
TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals No drug interventions treatment 1 / 2 active_not_recruiting NCT03706898
Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs treatment 1 completed NCT03160105
Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV) No drug interventions treatment 4 completed NCT06582797
Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor No drug interventions other Not Available not_yet_recruiting NCT03333083
Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen treatment 3 unknown_status NCT02489461
Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy treatment 2 / 3 completed NCT03118661
Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant No drug interventions supportive_care 1 withdrawn NCT03706911
Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects treatment 1 completed NCT04596488
Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients treatment Not Available completed NCT03244488
Mental Ability Challenge Study in Adults With and Without HIV Not Available Not Available completed NCT04340388
Contribution of Dolutegravir to Obesity and Cardiovascular Disease basic_science 4 completed NCT05374109
SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth No drug interventions treatment Not Available recruiting NCT03834909
Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P) prevention 1 withdrawn NCT05630885
A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV No drug interventions treatment 2 completed NCT03837015
Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women prevention 1 completed NCT04897737
Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP No drug interventions prevention Not Available completed NCT04557332
mHealth for ART Adherence by HIV+ African Americans No drug interventions treatment 2 completed NCT06203132
DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection treatment 3 not_yet_recruiting NCT04079452
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals treatment 3 completed NCT04429152
ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance treatment 3 unknown_status NCT03729752
PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) No drug interventions diagnostic 1 recruiting NCT05067400
SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort No drug interventions Not Available Not Available completed NCT05652400
HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia No drug interventions Not Available Not Available recruiting NCT04040075
Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy treatment 4 terminated NCT04051970
Reducing Antiretroviral Treatments No drug interventions treatment 3 unknown_status NCT05332470
A Real-world Study of Lamivudine and Dotiravir Sodium Tablets in the Treatment-naïve HIV-1 Infected Patients Not Available Not Available not_yet_recruiting NCT04233242
Genotype-Informed Versus Empiric Management of VirEmia No drug interventions diagnostic Not Available completed NCT04004299
Self-testing for HCV Re-infection in MSM No drug interventions diagnostic Not Available unknown_status NCT04063306
Quality of Life of Taiwan People Living With HIV No drug interventions Not Available Not Available unknown_status NCT04416906
A Test and Treat Strategy in New HIV Diagnosis. treatment 3 completed NCT03399136
Fitness and Longevity in Exercise No drug interventions other Not Available completed NCT04636736
HIV Drug Resistance Pattern Due to Migration in Poland No drug interventions Not Available Not Available unknown_status NCT03825536
Effect of Methamphetamine on Residual Latent HIV Disease Study basic_science 4 completed NCT04066036
Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa No drug interventions Not Available Not Available completed NCT04661813
Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV No drug interventions health_services_research Not Available completed NCT03129113
Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV treatment 2 / 3 completed NCT03927313
Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM treatment 2 completed NCT03606213
Therapeutic Vaccination in Treated HIV Disease treatment 1 / 2 completed NCT05526118
Advanced HIV: Outcomes for Rapid ART Not Available Not Available not_yet_recruiting NCT04938518
Latent HIV-1, Viral Suppress and Hope for HIV Cure No drug interventions Not Available Not Available unknown_status NCT04354818
Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) No drug interventions Not Available Not Available unknown_status NCT04173819
Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults prevention 1 / 2 active_not_recruiting NCT04459741
HIV, Immune Activation and Salt Sensitive Hypertension No drug interventions diagnostic Not Available completed NCT03757117
Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade No drug interventions health_services_research 4 completed NCT03536234
Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients treatment 2 unknown_status NCT06336434
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy No drug interventions treatment 1 / 2 not_yet_recruiting NCT03539224
Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept. treatment 2 unknown_status NCT03706924
Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects basic_science 1 completed NCT05481216
HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV No drug interventions Not Available Not Available completed NCT03297216
Improving Pregnancy Outcomes With Progesterone prevention 3 completed NCT04448158
Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy No drug interventions Not Available Not Available completed NCT05220358
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study treatment 4 recruiting NCT05163535
Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA® treatment 1 / 2 completed NCT03164135
Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances No drug interventions treatment Not Available unknown_status NCT04860063
Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. treatment 3 unknown_status NCT05144386
Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART No drug interventions treatment 1 active_not_recruiting NCT05044286
Longer-Acting PrEP in Transgender and Gender Diverse Texans No drug interventions Not Available Not Available completed NCT04884139
DTG/3TC Vs. BIC/FTC/TAF Maintenance Therapy in People Living with HIV: treatment 4 active_not_recruiting NCT04568239
Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES) No drug interventions Not Available Not Available completed NCT03902522
PRO 140 in Treatment-Experienced HIV-1 Subjects treatment 2 / 3 unknown_status NCT03532425
B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults treatment 4 terminated NCT05030025
Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg) treatment 0 completed NCT03848325
Poor Sleep and Inflammation in HIV-Infected Adults No drug interventions basic_science Not Available completed NCT04517825
More Than a Machine: Make Point-of-care HIV-1 Viral Load Testing Effective in Rural Uganda No drug interventions Not Available Not Available completed NCT04097925
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals treatment 2 completed NCT03525730
LRAs United as a Novel Anti-HIV Strategy. treatment 1 / 2 completed NCT04950530
The Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers treatment 1 recruiting NCT04495348
Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance Not Available Not Available completed NCT04311957
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults No drug interventions treatment 4 unknown_status NCT03472326
Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus treatment 2 terminated NCT04711265
Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys No drug interventions Not Available Not Available completed NCT05064020
Bictegravir in the Elderly Living With HIV (BICEP) Not Available Not Available active_not_recruiting NCT04201782
Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T No drug interventions Not Available Not Available terminated NCT01466582
Comorbidity and Aging With HIV No drug interventions Not Available Not Available active_not_recruiting NCT06580873
Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT) treatment 4 not_yet_recruiting NCT03519373
Pertussis Immunization During Pregnancy & HIV Infection No drug interventions Not Available Not Available completed NCT03772327
HIV Adherence Bottle Intervention Trial No drug interventions treatment Not Available completed NCT06247527
Psychoeducation, Relaxation, PrOblem Solving, Activation, Cognitive Coping Therapy for Adolescents and Youth in HIV Care No drug interventions treatment Not Available not_yet_recruiting NCT04143594
Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With Other Antiretroviral Agents in People Living With HIV treatment 2 completed NCT05204394
Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy treatment 2 / 3 unknown_status NCT04965662
The Role of Home Packs of HIV PEPSE in High Risk Individuals prevention 4 completed NCT03593629
Kenya HIV Self-Testing in PrEP Delivery No drug interventions health_services_research Not Available completed NCT03426189
HIV Persistence in Lymph Node and Peripheral Blood No drug interventions Not Available Not Available completed NCT03549689
Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) treatment 2 withdrawn NCT03101592
INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV No drug interventions health_services_research Not Available terminated NCT04311944
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD No drug interventions treatment Not Available unknown_status NCT03312244
Pyridostigmine as Immunomodulator in People Living With HIV treatment 2 suspended NCT04538040
Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine treatment 4 completed NCT05147740
Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age treatment 4 unknown_status NCT03478540
Gut Microbiota and Immune Recovery No drug interventions Not Available Not Available unknown_status NCT06071767
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 treatment 1 / 2 recruiting NCT04022967
ANRS 12372 MODERATO Study treatment 3 active_not_recruiting NCT04770701
Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes No drug interventions treatment 4 completed NCT05215704
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV No drug interventions Not Available Not Available recruiting NCT06031272
Pausing Antiretroviral Treatment Under Structured Evaluation treatment 1 recruiting NCT03580668
Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide Not Available Not Available completed NCT04979468
Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study) other 3 unknown_status NCT03493568
Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE) treatment 3 terminated NCT04963712
Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder treatment 0 completed NCT04738812
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression No drug interventions treatment 3 recruiting NCT05281510
Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women treatment 2 active_not_recruiting NCT03052010
The Partners Scale-Up Project No drug interventions prevention 4 completed NCT05642481
Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed No drug interventions Not Available Not Available recruiting NCT04296695
Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection treatment 4 active_not_recruiting NCT04880395
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 treatment 4 completed NCT04883255
Cannabis Use, Cognition, and the Endocannabinoid System in HIV basic_science 0 recruiting NCT03709355
Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs treatment 1 completed NCT05606055
The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection treatment 4 completed NCT05165550
Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects treatment 1 completed NCT02972450
An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection treatment 1 / 2 terminated NCT04002323
Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients Not Available Not Available completed NCT05040308
Uganda PrEP and Harm Reduction Evaluation No drug interventions health_services_research Not Available active_not_recruiting NCT05924438
A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy treatment 3 recruiting NCT03593538
Effects of Metformin During Nicotine Withdrawal treatment 2 completed NCT03961438
Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine prevention 1 completed NCT04266938
Impact of Rapid ART Initiation on Retention in Care in the Southern US No drug interventions other Not Available active_not_recruiting NCT05004038
BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: treatment 2 active_not_recruiting NCT05330143
Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV treatment 2 recruiting NCT05136703
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT) No drug interventions other Not Available recruiting NCT04229290
Second-line Switch to Dolutegravir Study treatment 4 completed NCT05418790
A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy No drug interventions device_feasibility Not Available unknown_status NCT03416790
IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment No drug interventions Not Available Not Available completed NCT04424264
The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants treatment 1 completed NCT05243602
BFTAF Elderly Switch Study treatment 4 completed NCT03198884
A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir Not Available Not Available completed NCT04593979
ANRS 12406 EvvA Study No drug interventions Not Available Not Available unknown_status NCT03813979
Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls. other 4 withdrawn NCT04341779
Simplifying Treatment and Monitoring for HIV (STREAM HIV) treatment Not Available completed NCT06492187
Triage Survey for Infectious Disease Eligibility No drug interventions Not Available Not Available recruiting NCT04027387
Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants No drug interventions treatment 1 completed NCT03183154
Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected No drug interventions Not Available Not Available unknown_status NCT04155554
Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen treatment 3 unknown_status NCT04480554
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 basic_science 2 recruiting NCT03194477
Providing Unique Support for Health (PUSH) Study No drug interventions health_services_research Not Available completed NCT03174977
Pharmacokinetics Distribution of Raltegravir by PET/MR No drug interventions other 0 recruiting NCT05459077
Addressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression No drug interventions health_services_research Not Available recruiting NCT05154747
Long-Acting Treatment in Adolescents (LATA) treatment 3 active_not_recruiting NCT03960645
Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters treatment 1 completed NCT03663998
Optimising DNA Vaccinations in Healthy Volunteers No drug interventions prevention 1 completed NCT05506605
Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance treatment 4 active_not_recruiting NCT03392805
Infectious Diseases and Movement Program: Study of the Effects of Physical Activity on HIV Infection No drug interventions treatment Not Available unknown_status NCT05584397
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART No drug interventions Not Available Not Available enrolling_by_invitation NCT03075397
VIH-1 Colo-rectal Transmission by Infected Semen Cells and Effects of Seminal Plasma ex Vivo (CellspermVIH) No drug interventions basic_science Not Available completed NCT04301661
Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites Not Available Not Available completed NCT04503928
Euphorbia Kansui and HIV/AIDS Functional Cure No drug interventions treatment 1 unknown_status NCT04553211
Expedited Partner Therapy and the HIV Prevention Cascade No drug interventions prevention Not Available completed NCT03729778
Impact of HIV-1 and Aging on Mucosal Vaccine Responses health_services_research 0 active_not_recruiting NCT05314088
Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV No drug interventions prevention Not Available enrolling_by_invitation NCT04024488
Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings No drug interventions supportive_care Not Available recruiting NCT05143307
Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101 No drug interventions other 1 enrolling_by_invitation NCT05585307
Study of Novel Antiretrovirals in Participants With HIV-1 treatment 1 completed NCT03875209
10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults No drug interventions treatment 1 completed NCT05604209
Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3m4 in Persons With HIV-1 Suppressed on ART No drug interventions treatment 1 recruiting NCT03837756
Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV treatment 2 completed NCT06358885
IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention No drug interventions health_services_research Not Available recruiting NCT04120415
A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02) treatment 2 completed NCT04098315
Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease. No drug interventions Not Available Not Available recruiting NCT05411237
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma treatment 3 not_yet_recruiting NCT03816137
Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens No drug interventions prevention 1 unknown_status NCT05896852
Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV No drug interventions treatment Not Available not_yet_recruiting NCT03234400
A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings prevention 1 completed NCT06507059
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals treatment 3 recruiting NCT04281459
Short Cycle Therapy in ART Regimens Containing Rilpivirine: Assessment of Patients' Satisfaction No drug interventions health_services_research Not Available completed NCT03866759
Prospective Observational Cohort HIV & STI Study in Europe No drug interventions Not Available Not Available completed NCT03646370
Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen Not Available Not Available completed NCT04094870
A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women treatment 4 completed NCT05271370
An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study treatment 2 / 3 unknown_status NCT05985642
Observational PIC Destination Cohort No drug interventions Not Available Not Available recruiting NCT05998499
HIV-Infected Latin American Asylum Seekers in Europe: Insights From the EuroLatin HIV Cohort No drug interventions Not Available Not Available completed NCT06022406
Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study No drug interventions treatment 2 recruiting NCT05096949
Implementing Cabenuva in Arkansas HIV Programs No drug interventions health_services_research Not Available terminated NCT04404049
The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients treatment 2 not_yet_recruiting NCT04050449
Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD No drug interventions Not Available Not Available completed NCT04255849
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV No drug interventions prevention 3 active_not_recruiting NCT03624413
InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media No drug interventions other Not Available completed NCT03570918
MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy No drug interventions treatment 1 completed NCT04067219
SkIn, Muscle and Bone Aging Determinants in HIV Infected-patients. No drug interventions basic_science Not Available completed NCT04253119
ART First-line Treatment Durability in Russia No drug interventions Not Available Not Available completed NCT04068441
Measurement for Viral Reservoir and Immune Function in HIV-1-infected Patients Under Antiretroviral Therapy No drug interventions Not Available Not Available completed NCT01437241
Etravirine Plus 2 Analogs in HIV-infected Patients No drug interventions Not Available Not Available completed NCT04968717
2000HIV Trained Innate Immunity in HIV Elite Controllers No drug interventions Not Available Not Available completed NCT06554717
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV treatment 2 not_yet_recruiting NCT04553016
A Study to Test Three Experimental HIV Vaccines in Healthy Adults. No drug interventions prevention 1 unknown_status NCT04513496
Telemedicine in HIV Care in Buenos Aires No drug interventions Not Available Not Available unknown_status NCT05156658
Pharmacokinetic Interactions of ENG Subdermal Implants With Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA) treatment 4 withdrawn NCT04050735
Acute Neural and Immune Effects of Alcohol in People Living With HIV Infection No drug interventions basic_science Not Available recruiting NCT05890963
10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults treatment 1 recruiting NCT05051163
Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition treatment 2 / 3 unknown_status NCT03074786
Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH) prevention 2 withdrawn NCT05414786
A Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) No drug interventions prevention 1 active_not_recruiting NCT05421286
The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events No drug interventions Not Available Not Available active_not_recruiting NCT04638686
REal-Life Cohort With DOlutegravir + LAmivudina Not Available Not Available completed NCT03360422
ANCHORS Study: UH2 Project No drug interventions prevention Not Available completed NCT04225325
Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI). treatment 4 unknown_status NCT05973825
Immuno-virological Evaluation of Persons Living With HIV (PLWH) No drug interventions basic_science Not Available not_yet_recruiting NCT05700630
Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia treatment 1 withdrawn NCT04894357
Impact of V106I on Resistance to Doravirine No drug interventions Not Available Not Available unknown_status NCT04009057
Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF) No drug interventions Not Available Not Available completed NCT05668026
Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART treatment 1 / 2 recruiting NCT05634265
Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study No drug interventions supportive_care Not Available completed NCT04718974
Call for Life Youth ART Adherence Study No drug interventions supportive_care Not Available completed NCT03360682
Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients treatment 4 unknown_status NCT05405582
Thetha Nami Ngithethe Nawe ("Let's Talk"): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa No drug interventions prevention Not Available recruiting NCT02432482
A Mobile Intervention to Promote Cessation in HIV-infected Smokers No drug interventions treatment Not Available completed NCT03227731
Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women other 2 / 3 completed NCT03226873
Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV No drug interventions prevention Not Available completed NCT03589027
Darunavir and Rilpivirine Interactions With Levonorgestrel Implant treatment 2 unknown_status NCT05140876
Supporting Treatment Adherence for Resilience and Thriving (START) No drug interventions other Not Available recruiting NCT03998176
Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE treatment 4 completed NCT03329560
Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV treatment 1 completed NCT04620291
Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults treatment 1 not_yet_recruiting NCT04563962
Contingency Management for PrEP Adherence and/or Methamphetamine Use No drug interventions prevention Not Available completed NCT03110380
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed treatment 3 completed NCT05660980
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age No drug interventions treatment 1 / 2 recruiting NCT04433780
DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV treatment 3 completed NCT04330989
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women No drug interventions prevention Not Available completed NCT05381844
Quantification of Antisense HIV RNA in Patients No drug interventions Not Available Not Available recruiting NCT04238767
Dolutegravir in Real Life in Lesotho Not Available Not Available completed NCT04549467
Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test treatment 4 completed NCT05852301
Optimising Cohorts for HIV Cure Interventions No drug interventions Not Available Not Available recruiting NCT05495204
External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA Not Available Not Available completed NCT04388904
Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART) treatment 4 completed NCT05306704
High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial No drug interventions supportive_care 3 completed NCT03567304
Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine treatment 4 unknown_status NCT04150068
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance treatment 2 / 3 active_not_recruiting NCT04067869
Cytomegalovirus Infection in Patients With HIV-1 Infection No drug interventions treatment 3 completed NCT03705169
Pharmacokinetics and Safety of SAR441236 No drug interventions treatment 1 terminated NCT05769569
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission treatment 1 withdrawn NCT03549312
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy treatment 4 unknown_status NCT03512210
Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection treatment 4 completed NCT03249181
Dolutegravir in Pregnant HIV Mothers and Their Neonates treatment 3 completed NCT03579381
Specimen Repository for HIV Immunopathogenesis No drug interventions Not Available Not Available completed NCT04553081
2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial No drug interventions treatment 4 recruiting NCT03512795
Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations No drug interventions Not Available Not Available completed NCT03913195
Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection treatment 3 completed NCT03797014
B/F/TAF Switch Study for HIV-HBV Coinfection treatment 4 completed NCT04174755
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV treatment Not Available recruiting NCT03706950
Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART No drug interventions Not Available Not Available unknown_status NCT03774108
Metformin and Systemic Inflammation in HIV treatment 4 unknown_status NCT05349838
An Open-Label, Multi-Centre, Randomised, Switch Study to Evaluate the Virological Efficacy Over 96 Weeks Of 2-Drug Therapy With DTG/RPV FDC in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTIs Resistance Mutation K103N treatment 3 completed NCT05654051
The SLIM LIVER Study treatment 2 active_not_recruiting NCT03902418
Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women Not Available Not Available active_not_recruiting NCT01379703
Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use No drug interventions Not Available Not Available completed